Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
04. November 2024 08:57 ET
|
Royal Philips
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery...
Ruff & Whiskerz Bamboo Pads Nab Pet Innovation Award For “Waste Innovation of the Year”
15. August 2024 08:05 ET
|
Pet Innovation Awards
LOS ANGELES, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The 2024 Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
09. Mai 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
08. Mai 2024 12:00 ET
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the first time that coronary CTA (CCTA) with...
Occlusion Perfusion Catheter Demonstrates Superior Performance in PAD Drug Delivery
02. November 2023 08:28 ET
|
Advanced Catheter Therapies
Researchers successfully demonstrate the delivery of liquid sirolimus into the arterial wall using the OPC, which can also be used for paclitaxel BTK.
The Global Feminine Hygiene (disposable sanitary pad, reusable pad, tampons, menstrual cup, panty liner, internal cleansers & sprays, disposable razor & blades) Market to Surpass USD 58 Billion by 2027: Bonafide Research
10. Februar 2023 02:00 ET
|
Bonafide Research & Marketing Pvt. Ltd.
Clifton, New Jersey, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The change in female buying patterns, e-commerce penetration, influence through social media platforms, endorsements by famous celebrities,...
Endonovo Therapeutics Releases Comparative Analysis Demonstrating
28. Juli 2022 09:08 ET
|
Endonovo Therapeutics, Inc.
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior...
Endonovo Therapeutics Announces LOI to Acquire Specialty Construction Company
09. Juni 2022 14:02 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, June 09, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today announced a Letter of Intent to purchase a highly-regarded market leading specialty concrete services...
$5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursement
11. April 2022 09:08 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 11, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced significant advancement in the of process to obtain medical reimbursements for its...
Endonovo Therapeutics Inc. (ENDV) Announces it has filed a Regulation A+ Financing & Retained Dalmore Group to Provide Operations & Compliance
16. Februar 2022 09:10 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTC-ENDV) an Innovative Medical Devices developer and distributor is pleased to announce it has filed a Regulation A+...